Abstract

Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity

Author(s): Biundo Bruce, Gogola Margaret

Issue: Jul/Aug 2015 - Volume 19, Number 4

Page(s): 289-293

Download in electronic PDF format for $75
  • Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 1
  • Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 2
  • Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 3
  • Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 4
  • Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Page 5

Abstract

Estrogen therapy is a well-known and commonly used symptomatic treatment of hot flashes, night sweats and vaginal dryness associated with menopause. The most active estrogen, estradiol, is also understood to have a protective effect against osteoporosis. Like many hormones, though, estradiol has many roles in the body, both in males and females, and studies of these roles continue to emerge. A major function of estradiol involves obesity, insulin resistance, and cardiovascular disease; studies have shown the beneficial effects of estradiol in these areas, and this is somewhat at variance with traditional belief. In recent years, many researchers have studied its protective, beneficial effect, and have arrived at convincing evidence. In females, and, to some extent in males, estradiol is very important in protecting against obesity and lessening the likelihood of insulin resistance and cardiovascular disease. For both menopausal women and hypogonadal men, estradiol levels should be monitored and considered for long-term healthcare benefits.

Related Keywords

  • menopausal women
  • hypogonadal men
  • estrogen replacement therapy
  • estradiol
  • menopause
  • osteoprotection
  • osteoporosis
  • obesity
  • insulin resistance
  • diabetes
  • cardiovascular disease
  • visceral adipose tissue
  • aromatase
  • sex hormones
  • estrogen receptors
  • weight gain
  • fatty acid oxidation
  • adipocytokines
  • insulin sensitivity

Related Categories

  • DIABETES
  • HRT
  • CARDIOLOGY
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2015
Pg. 289-293
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Author(s): Biundo Bruce, Gogola Margaret
Jan/Feb 2003
Pg. 10-15
View Sample
Compounding for the Effects of Weapons of Mass Destruction
Author(s): Sammarco Domenic A
May/Jun 2003
Pg. 170-174
Five Compounds for Treating Diabetes-Related Conditions
Author(s): Meece Jerry
Mar/Apr 2010
Pg. 94-99
Emerging Evidence for Androgen Replacement Therapy in Aging Men
Author(s): Bramwell Bethany L
Nov/Dec 2016
Pg. 447-454
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Author(s): Deleruyelle Laura J
Mar/Apr 2000
Pg. 103-104
Diabetes Book Reviews
Author(s): Reed-Kane Dana
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Mar/Apr 2000
Pg. 88-90
Complications of Diabetes
Author(s): Key David M
May/Jun 2004
Pg. 175-178
Andropause: New Perspectives
Author(s): Biundo Bruce
Sep/Oct 2003
Pg. 330-338
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2
Author(s): Gillson George R, Zava David T
Jul/Aug 2003
Pg. 250-256
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Author(s): Gillson George R, Zava David T
Jan/Feb 2017
Pg. 6-16
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Author(s): Deleruyelle Laura J
Mar/Apr 2010
Pg. 165-170
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Author(s): Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Jan/Feb 2015
Pg. 6-12
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2004
Pg. 10-14
Women's Oral Health: Is There a Hormonal Link?
Author(s): Preckshot John
Nov/Dec 2010
Pg. 465-471
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women
Author(s): Bramwell Bethany L
Jan/Feb 2004
Pg. 16-21
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Author(s): Cutter Christopher B
May/Jun 2018
Pg. 190-195
Establishing a Rationale for Compounding Hormone Replacement Therapy
Author(s): Biundo Bruce
Jan/Feb 2024
Pg. 22-27
Establishing a Rationale for Compounding Hormone Replacement Therapy
Author(s): Biundo Bruce